Amyotrophic Lateral Sclerosis
📧 Sign up to get email alerts when something new happens for Amyotrophic Lateral Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Collection of Blood Samples for DNA in Motor Neuron Disease
Update on a clinical trial collecting blood samples for DNA to study motor neuron diseases; no treatment results are reported in this docume…
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Amyotrophic Lateral Sclerosis and the Innate Immune System
A Denmark-based clinical trial sponsored by Rigshospitalet is currently recruiting to investigate the role of the innate immune system in am…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS) [Phase 1]
Phase 1 pilot trial evaluating inosine in people with amyotrophic lateral sclerosis has completed with results posted.
-
CLINICAL_TRIALS research · 2017-08-08Clinical Trial Update: A Programme for Amyotrophic Lateral Sclerosis Care in Europe
This document reports an ongoing European program designed to improve care for people with amyotrophic lateral sclerosis (ALS) and motor neu…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients [Phase 1]
Phase 1 trial evaluating escalated application of mesenchymal stem cells in amyotrophic lateral sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS [Phase 1]
This entry provides a status update on a Phase 1 multiple-dose safety and tolerability study (CC100) in subjects with amyotrophic lateral sc…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
This document reports the completion and results posting of a Phase 2 trial evaluating immunosuppression in amyotrophic lateral sclerosis (A…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort
The update confirms self-reported incident ALS cases in the AARP-Diet and Health cohort. It describes methods used to validate these cases.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
A completed clinical trial investigates whether exposure to environmental neurotoxins is a risk factor for amyotrophic lateral sclerosis (AL…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Mexiletine for the Treatment of Muscle Cramps in ALS [Phase 4]
Phase 4 trial evaluating mexiletine for reducing muscle cramps in amyotrophic lateral sclerosis completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]
Phase 1/2 trial assessing SOD1 inhibition by pyrimethamine in familial amyotrophic lateral sclerosis has completed; results were posted in 2…
-
CLINICAL_TRIALS withdrawal · 2017-05-31Clinical Trial Update: Microglial Activation Role In ALS (MARIA) [EARLY_Phase 1]
The MARIA trial, an early phase 1 study examining microglial activation in amyotrophic lateral sclerosis, has been withdrawn.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
Massachusetts General Hospital completed a longitudinal study investigating biomarkers in amyotrophic lateral sclerosis, contributing data o…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of MCI-186 (edaravone) for amyotrophic lateral sclerosis has completed, with results post…
-
FDA approval · 2017-05-05FDA Approved: RADICAVA — Original Application (Shionogi Inc.)
FDA approved the original application for RADICAVA (edaravone) by Shionogi Inc. for the treatment of amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS [Phase 1]
Phase 1 trial evaluating intravenous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis has completed.
-
CLINICAL_TRIALS research · 2017-04-26Clinical Trial Update: Trial of Amivita in Amyotrophic Lateral Sclerosis [NA]
A clinical trial update for Amivita in amyotrophic lateral sclerosis, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]
Phase 2 trial of ozanezumab vs placebo in amyotrophic lateral sclerosis completed with results posted.
-
CLINICAL_TRIALS research · 2017-04-13Clinical Trial Update: Virtual Task in Amyotrophic Lateral Sclerosis [NA]
Completed clinical trial update from the University of Sao Paulo on a virtual task study in amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) [Phase 1, Phase 2]
A clinical trial tested autologous bone marrow stem cell therapy in amyotrophic lateral sclerosis and has completed Phase 1/2 testing.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial update on an EEG-based brain-computer interface project for individuals with amyotrophic lateral sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis [Phase 1]
Phase 1 clinical trial investigating intramuscular infusion of autologous bone marrow stem cells in patients with Amyotrophic Lateral Sclero…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Clinical Trial Nuedexta in Subjects With ALS [Phase 2]
Phase 2 clinical trial results for Nuedexta in individuals with amyotrophic lateral sclerosis were posted in March 2017.
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Longitudinal Study of Outcomes Measures in ALS Trials
This update reports on a longitudinal study of outcome measures used in amyotrophic lateral sclerosis trials to evaluate and standardize how…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: An In-home Study of Brain Computer Interfaces [NA]
This document reports the results of an in-home brain-computer interface study in people with Amyotrophic Lateral Sclerosis. The trial is co…